Marc G. Odrich
Chief Medical OfficerMr. Marc G. Odrich, M.D. serves as Senior Medical Advisor & Director of CXL Ophthalmics, Inc. He has been in both private and academic practice and is an Associate Professor of Ophthalmology at the University of Virginia where he practices clinical ophthalmology specializing in Refractive Surgery. He has had pivotal roles in the development and commercialization of the excimer laser and the femto laser as former Medical Director for Visx, Inc and consults for multiple companies in the areas of corneal and refractive surgery, presbyopia correction and dry eye disease. He was the Chief Medical Officer for TearSolutions, Inc. a Charlottesville, VA based start up that is in clinical trials with a new drug developed for Sjogrens and dry eye disease. He is Chief Medical Officer of LENZ THERAPEUTICS, INC. since March 21, 2024 and served as LENZ OpCo’s Chief Medical Officer from July 2021 through the closing of the Merger and provided consulting services to LENZ OpCo from March 2018 to July 2021. He is a clinical ophthalmologist specializing in refractive surgery to correct conditions such as nearsightedness, farsightedness and astigmatism. In his previous roles as medical Director and consultant for surgical technology companies, he’s played a pivotal role in the development and commercialization of the excimer laser and the femto laser. He continues to share his knowledge as a consultant working with multiple companies to advance corneal and refractive surgery, presbyopia correction and dry eye disease treatment. He is a graduate of Columbia College and received his medical degree from Columbia University College of Physicians and Surgeons. He completed an internship in internal medicine at Yale’s Danbury Hospital before moving on to pursue his residency at Columbia’s Harkness Eye Institute. He focused on cornea and external disease at Harvard’s Massachusetts Eye and Ear Infirmary for two years. He received 2019-2020 Best Doctors in America® List. He completed Fellowships from Massachusetts Eye and Ear Infirmary, Harvard University. Mr. Odrich has B.A. in Ancient History from Columbia University in the City of New York and M. D. from Columbia University College of Physicians & Surgeons in New York in 1984.
Positions
- Company NameLENZ Therapeutics, Inc.Stock CodeLENZPositionChief Medical OfficerColleagues
- EBEvert B. SchimmelpenninkPresident, CEO, Secretary & Director
- JPJeffrey P. GeorgeIndependent Chairman
- JWJames W. McCollumCo-Founder & Director
- SOShawn OlssonChief Commercial Officer
- DRDaniel R. ChevallardCFO, Principal Financial & Accounting Officer
- FGFrederic GuerardIndependent Director
- SBShelley B. ThunenIndependent Director
